FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.19B
AUM Growth
-$221M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$45.5M
2
+$15.5M
3
+$15.1M
4
ZLAB icon
Zai Lab
ZLAB
+$12.6M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$10.1M

Top Sells

1
+$63.1M
2
+$33.9M
3
+$20.8M
4
KRYS icon
Krystal Biotech
KRYS
+$18M
5
PLRX icon
Pliant Therapeutics
PLRX
+$14.8M

Sector Composition

1 Healthcare 99.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$17.6M 0.8%
7,819,863
+2,722,084
27
$15.7M 0.72%
373,100
28
$15.5M 0.71%
+525,000
29
$15.4M 0.7%
10,617,062
30
$15.1M 0.69%
+1,443,341
31
$12.6M 0.58%
+350,000
32
$8.94M 0.41%
301,170
+192,408
33
$7.87M 0.36%
1,410,193
-2,478,045
34
$7.81M 0.36%
470,338
35
$7.54M 0.34%
1,953,547
36
$7.2M 0.33%
1,079,025
-400,000
37
$7.17M 0.33%
4,623,324
38
$5.98M 0.27%
583,327
39
$5.65M 0.26%
3,868,750
+1,001,000
40
$5.63M 0.26%
1,247,911
-900,000
41
$5.61M 0.26%
936,576
42
$4.67M 0.21%
1,069,244
43
$4.5M 0.21%
500,333
44
$4.03M 0.18%
3,175,665
45
$3.32M 0.15%
955,515
46
$3.24M 0.15%
1,148,591
47
$1.55M 0.07%
5,993,579
48
– –
-1,573,719
49
– –
-285,331
50
– –
-689,655
1
2
3